These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29223589)
1. Breakthroughs in neuroactive steroid drug discovery. Blanco MJ; La D; Coughlin Q; Newman CA; Griffin AM; Harrison BL; Salituro FG Bioorg Med Chem Lett; 2018 Jan; 28(2):61-70. PubMed ID: 29223589 [TBL] [Abstract][Full Text] [Related]
2. Neurosteroid modulation of N-methyl-D-aspartate receptors: molecular mechanism and behavioral effects. Korinek M; Kapras V; Vyklicky V; Adamusova E; Borovska J; Vales K; Stuchlik A; Horak M; Chodounska H; Vyklicky L Steroids; 2011 Dec; 76(13):1409-18. PubMed ID: 21925193 [TBL] [Abstract][Full Text] [Related]
3. Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21. Martinez Botella G; Salituro FG; Harrison BL; Beresis RT; Bai Z; Shen K; Belfort GM; Loya CM; Ackley MA; Grossman SJ; Hoffmann E; Jia S; Wang J; Doherty JJ; Robichaud AJ J Med Chem; 2015 Apr; 58(8):3500-11. PubMed ID: 25799373 [TBL] [Abstract][Full Text] [Related]
4. Involvement of Neuroactive Steroids in Pain, Depression and Anxiety. Mifflin K; Benson C; Kerr B; Aricioglu F; Cetin M; Dursun S; Baker G Mod Trends Pharmacopsychiatry; 2015; 30():94-102. PubMed ID: 26436548 [TBL] [Abstract][Full Text] [Related]
5. Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo. Cauli O; González-Usano A; Agustí A; Felipo V Neuroscience; 2011 Sep; 190():27-36. PubMed ID: 21703332 [TBL] [Abstract][Full Text] [Related]
6. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Cutler AJ; Mattingly GW; Maletic V Transl Psychiatry; 2023 Jun; 13(1):228. PubMed ID: 37365161 [TBL] [Abstract][Full Text] [Related]
7. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. Monnet FP; Maurice T J Pharmacol Sci; 2006 Feb; 100(2):93-118. PubMed ID: 16474209 [TBL] [Abstract][Full Text] [Related]
9. Neuroactive steroids as endogenous modulators of anxiety. Eser D; Baghai TC; Schüle C; Nothdurfter C; Rupprecht R Curr Pharm Des; 2008; 14(33):3525-33. PubMed ID: 19075729 [TBL] [Abstract][Full Text] [Related]
10. Interaction of steroids with the GABA(A) receptor. Hamilton NM Curr Top Med Chem; 2002 Aug; 2(8):887-902. PubMed ID: 12171578 [TBL] [Abstract][Full Text] [Related]
11. Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system. Mellone M; Gardoni F Eur J Pharmacol; 2013 Nov; 719(1-3):75-83. PubMed ID: 23872417 [TBL] [Abstract][Full Text] [Related]
12. The sticky issue of neurosteroids and GABA(A) receptors. Chisari M; Eisenman LN; Covey DF; Mennerick S; Zorumski CF Trends Neurosci; 2010 Jul; 33(7):299-306. PubMed ID: 20409596 [TBL] [Abstract][Full Text] [Related]
13. Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo. González-Usano A; Cauli O; Agustí A; Felipo V J Neurochem; 2013 Apr; 125(1):133-43. PubMed ID: 23227932 [TBL] [Abstract][Full Text] [Related]
14. Access of inhibitory neurosteroids to the NMDA receptor. Borovska J; Vyklicky V; Stastna E; Kapras V; Slavikova B; Horak M; Chodounska H; Vyklicky L Br J Pharmacol; 2012 Jun; 166(3):1069-83. PubMed ID: 22188257 [TBL] [Abstract][Full Text] [Related]
15. [Neurosteroids and their function]. Bicíková M; Hampl R Cas Lek Cesk; 2007; 146(3):223-6. PubMed ID: 17419304 [TBL] [Abstract][Full Text] [Related]